Assessing the levels of transforming growth factor beta 1 and vascular endothelial growth factor during orthodontic treatment in patients of mangaluru
Not Applicable
- Conditions
- Health Condition 1: K039- Disease of hard tissues of teeth,unspecified
- Registration Number
- CTRI/2024/03/064606
- Lead Sponsor
- Dr Shebah Catherine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients requiring fixed orthodontic treatment.
2) Age 14 to 25 years
3) Patients with good oral hygiene.
4) Healthy patients without any medication
5) Patients requiring premolar extraction
Exclusion Criteria
1) Patients with systemic health issues.
2) Patients taking antibiotics, sialogogues and antisialogogues.
3) Patients with habits such as smoking, pan chewing, gutka, etc
4) Patients with congenital deformity.
5) Patients requiring surgical intervention or dentofacial orthopedics.
6) Treatment with removable and functional appliances.
7) Patients with diseases where salivary flow is affected such as Sjögren Syndrome, ectodermal dysplasia, chronic sialadenitis, etc
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase in the levels of Transforming growth factor and vascular endothelial growth factor as the treatment progressesTimepoint: one year
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI